- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/033 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
Patent holdings for IPC class C07D 295/033
Total number of patents in this class: 76
10-year publication summary
|
3
|
7
|
7
|
7
|
6
|
5
|
7
|
8
|
6
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Omeros Corporation | 305 |
5 |
| Qatar University | 188 |
3 |
| Daegu-gyeongbuk Medical Innovation Foundation | 116 |
3 |
| Sage Therapeutics, LLC | 167 |
3 |
| The Trustees of the University of Pennsylvania | 4448 |
2 |
| Chemo Research, S.L. | 105 |
2 |
| Infineum International Limited | 458 |
2 |
| SK Biopharmaceuticals Co., Ltd. | 279 |
2 |
| Curia Spain, S.A.U. | 31 |
2 |
| Glaxo Group Limited | 4361 |
1 |
| BASF SE | 21339 |
1 |
| LG Chem, Ltd. | 18005 |
1 |
| The Regents of the University of California | 20989 |
1 |
| Bayer Pharma AG | 1001 |
1 |
| DSM IP Assets B.V. | 5405 |
1 |
| Abbvie Inc. | 1812 |
1 |
| Japan Science and Technology Agency | 1207 |
1 |
| Allergan Pharmaceuticals International Limited | 230 |
1 |
| Ardelyx, Inc. | 119 |
1 |
| Aurimmed Pharma, Inc. | 7 |
1 |
| Other owners | 41 |